A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters
The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.
MOSCOW, Russia: The Russian central bank has implemented a range of capital controls in a bid to support domestic assets...
Business and political leaders gathered in the Swiss hilltop town of Davos in May 2022 for the World Economic Forum....
Jerome Powell departing after taking the oath of office for his second term as Federal Reserve chair on Monday. AFP...
TipRanks 2 “Strong Buy” Stocks Under $10 That Are Too Cheap to Ignore The current market conditions – the NASDAQ...
Russian President Vladimir Putin delivers a speech during a ceremony honouring the country's Olympians and Paralympians at the Kremlin in...
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
